Innovative Automated Insulin Delivery System for T2D
ClinicalTrials.gov NCT06853990
Research payments
$4,230,047
Through program year 2025, $4,230,047 in research payments was reported against Innovative Automated Insulin Delivery System for T2D, across 3,746 payments, paid by Sequel Med Tech, LLC.
- Paid by
- Sequel Med Tech, LLC
- ClinicalTrials.gov
- NCT06853990
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $4,230,047 | 3,746 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Davida Kruger Detroit, MI Named on 254 payments
- Carol Levy New York, NY Named on 221 payments
- Yogish Kudva Rochester, MN Named on 204 payments
- David Liljenquist Idaho Falls, ID Named on 194 payments
- Anders Carlson St Louis Park, MN Named on 184 payments
- Thomas Blevins Austin, TX Named on 182 payments
- Anuj Bhargava Des Moines, IA Named on 156 payments
- John Reed Roswell, GA Named on 154 payments
- Timothy Graham Sandy, UT Named on 154 payments
- Kathleen Dungan Columbus, OH Named on 152 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.